)
The Chemours Company (CC) investor relations material
The Chemours Company Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 net sales rose 3% YoY to $1.54B; Adjusted EBITDA increased 6% to $200M, led by TT pricing and APM growth, partly offset by TSS weakness and higher costs.
GAAP net income was $196M, or $1.29/share, including $150M of PFAS insurance proceeds; Adjusted Net Income was $31M.
Execution included debt reduction, cost and operating initiatives, environmental settlements, and completion of the Kuan Yin land sale.
Financial highlights
Net sales were $1.54B, up $45M YoY and down $51M QoQ; pricing rose 5%, volumes fell 2%, and currency was a slight headwind.
Adjusted EBITDA was $200M, up $11M YoY and down $47M QoQ; adjusted net income was $31M and adjusted diluted EPS was $0.21.
Operating cash flow was $149M, capex $51M, and free cash flow $98M; Q3 free-cash-flow conversion was 49% versus 56% a year earlier.
GAAP net income of $196M included $150M of PFAS insurance proceeds and Kuan Yin land-sale gains; Q3 COGS rose 4% amid higher unit costs and lower production rates.
Nine-month net sales were $4.51B; net loss was $107M, including a $307M tax provision and substantial environmental and litigation charges.
Outlook and guidance
FY2026 net sales are expected to grow ~2%; Adjusted EBITDA guidance is $775M–$800M, capex $220M–$230M, free-cash-flow conversion 15%–20%, and net leverage below 4.2x.
Q4 net sales are expected to decline 5%–10% sequentially; Adjusted EBITDA is forecast at $160M–$185M, with positive free cash flow.
Q4 TSS sales are expected to decline high-teens to low-twenties sequentially, with Adjusted EBITDA of $105M–$115M; TT sales are expected down high-single digits to low-teens, with EBITDA of $60M–$65M.
Q4 APM sales are expected to rise low- to mid-teens sequentially, with Adjusted EBITDA of $40M–$45M, supported by Performance Solutions orders.
Earnings growth is expected in 2027 despite macro uncertainty; expected environmental remediation spending over three years is $227M at five significant sites and $63M at other sites.
- Q2 2026 delivered strong cash flow, margin expansion, and strategic progress in high-growth markets.CC
Investor presentation - Adjusted EBITDA was $247M on flat sales, with improved cash flow and lower net loss year-over-year.CC
Q2 2026 - Virtual annual meeting set for April 2026 with key votes on directors, pay, and auditor.CC
Proxy filing - TSS strength drove $1.4B sales and $169M EBITDA, despite wider net loss and TT/APM declines.CC
Q1 2026 - 2025 net sales reached $5.8B, driven by Opteon growth, cost savings, and asset optimization.CC
Investor presentation - Board refreshment, strategic execution, and ESG progress headline this year's proxy.CC
Proxy Filing - TSS Opteon™ growth and strong cash flow drive 2026 outlook amid TT/APM headwinds.CC
Q4 2025 - Q3 2024 featured strong Opteon™ growth, TT margin gains, and ongoing cost reduction initiatives.CC
Investor presentation - Chemours targets growth in refrigerants and data center cooling while managing PFAS liabilities.CC
Gabelli Funds' 16th Annual Specialty Chemicals Symposium
Next The Chemours Company earnings date
Next The Chemours Company earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)